Brain Scientific Past Earnings Performance
Past criteria checks 0/6
Brain Scientific's earnings have been declining at an average annual rate of -55.6%, while the Medical Equipment industry saw earnings growing at 9.1% annually. Revenues have been growing at an average rate of 20.3% per year.
Key information
-55.6%
Earnings growth rate
-23.6%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 20.3% |
| Return on equity | -285.9% |
| Net Margin | -5,753.0% |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Brain Scientific makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 0 | -12 | 9 | 0 |
| 30 Sep 22 | 0 | -15 | 13 | 0 |
| 30 Jun 22 | 0 | -12 | 11 | 0 |
| 31 Mar 22 | 0 | -11 | 10 | 0 |
| 31 Dec 21 | 0 | -9 | 8 | 0 |
| 30 Sep 21 | 0 | -3 | 5 | 0 |
| 30 Jun 21 | 0 | -2 | 4 | 0 |
| 31 Mar 21 | 0 | -3 | 3 | 0 |
| 31 Dec 20 | 0 | -3 | 3 | 0 |
| 30 Sep 20 | 1 | -4 | 1 | 0 |
| 30 Jun 20 | 1 | -3 | 1 | 0 |
| 31 Mar 20 | 1 | -2 | 1 | 0 |
| 31 Dec 19 | 0 | -1 | 1 | 0 |
| 30 Sep 19 | 0 | -1 | 1 | 0 |
| 30 Jun 19 | 0 | -1 | 1 | 0 |
| 31 Mar 19 | 0 | -2 | 1 | 0 |
| 31 Dec 18 | 0 | -1 | 1 | 0 |
| 30 Sep 18 | 0 | -1 | 1 | 0 |
| 30 Jun 18 | 0 | -1 | 1 | 0 |
| 31 Mar 18 | 0 | -1 | 1 | 0 |
| 31 Dec 17 | 0 | -1 | 1 | 0 |
Quality Earnings: BRSF is currently unprofitable.
Growing Profit Margin: BRSF is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BRSF is unprofitable, and losses have increased over the past 5 years at a rate of 55.6% per year.
Accelerating Growth: Unable to compare BRSF's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BRSF is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.7%).
Return on Equity
High ROE: BRSF has a negative Return on Equity (-285.92%), as it is currently unprofitable.